Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Aibin Liang, MD,Ph.D.
CONTACT
Ping Li, MD,Ph.D.
CONTACT
Lead
Shanghai AbelZeta Ltd.
With
This is a single arm, single-center, non-randomized study to evaluate the safety and efficacy of C-CAR011 therapy in relapsed or refractory B cell Non-Hodgkin Lymphoma (NHL). The study will include the following sequential phases: Screening, Pre-Treatment (Cell Product Preparation; Lymphodepleting Chemotherapy), Treatment and Follow-up.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted